Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10428 | 1065 | 41.8 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
329 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 18133 |
10428 | 1 | BAZEDOXIFENE//RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX | 1065 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BAZEDOXIFENE | authKW | 1191618 | 6% | 62% | 67 |
2 | RALOXIFENE | authKW | 1109262 | 18% | 20% | 189 |
3 | TISSUE SELECTIVE ESTROGEN COMPLEX | authKW | 569440 | 2% | 83% | 24 |
4 | SELECTIVE ESTROGEN RECEPTOR MODULATOR | authKW | 483957 | 8% | 20% | 83 |
5 | LASOFOXIFENE | authKW | 409888 | 2% | 62% | 23 |
6 | TSEC | authKW | 379454 | 1% | 88% | 15 |
7 | SERM | authKW | 241248 | 5% | 17% | 50 |
8 | CONJUGATED ESTROGENS | authKW | 231686 | 3% | 29% | 28 |
9 | BREAST CANCER PREVENTION | authKW | 225324 | 2% | 30% | 26 |
10 | MIDLIFE HLTH | address | 224762 | 1% | 56% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4605 | 35% | 0% | 370 |
2 | Obstetrics & Gynecology | 4194 | 19% | 0% | 207 |
3 | Medicine, General & Internal | 693 | 13% | 0% | 140 |
4 | Endocrinology & Metabolism | 679 | 11% | 0% | 115 |
5 | Geriatrics & Gerontology | 554 | 4% | 0% | 44 |
6 | Pharmacology & Pharmacy | 265 | 12% | 0% | 124 |
7 | Women’s Studies | 236 | 2% | 0% | 16 |
8 | Reproductive Biology | 197 | 3% | 0% | 32 |
9 | Public, Environmental & Occupational Health | 81 | 5% | 0% | 53 |
10 | Primary Health Care | 76 | 1% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MIDLIFE HLTH | 224762 | 1% | 56% | 14 |
2 | PREVENT OUTREACH PROGRAMS | 57340 | 0% | 100% | 2 |
3 | EARLY DETECT COMMUNITY ONCOL PROGRAM | 51604 | 0% | 60% | 3 |
4 | LYNN SAGE BREAST CANC PROGRAM | 38222 | 0% | 33% | 4 |
5 | CANC PREVENT GENET | 34449 | 1% | 9% | 14 |
6 | SURG ADJUVANT BREAST BOWEL PROJECT | 30528 | 1% | 15% | 7 |
7 | ANTHROPOL INVEST | 28670 | 0% | 100% | 1 |
8 | BAYLOR CANC | 28670 | 0% | 100% | 1 |
9 | BESINS INT | 28670 | 0% | 100% | 1 |
10 | BRANCH MED STAT BIOMETRY | 28670 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 28093 | 4% | 2% | 47 |
2 | MATURITAS | 7179 | 3% | 1% | 30 |
3 | CLIMACTERIC | 6886 | 2% | 2% | 16 |
4 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 4490 | 2% | 1% | 20 |
5 | BREAST CANCER RESEARCH AND TREATMENT | 4012 | 3% | 0% | 32 |
6 | BREAST CANCER RESEARCH | 2946 | 1% | 1% | 15 |
7 | CANCER PREVENTION RESEARCH | 2326 | 1% | 1% | 10 |
8 | BREAST JOURNAL | 2204 | 1% | 1% | 9 |
9 | JOURNAL OF CLINICAL ONCOLOGY | 1880 | 3% | 0% | 33 |
10 | MEDSCAPE WOMENS HEALTH | 1788 | 0% | 3% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BAZEDOXIFENE | 1191618 | 6% | 62% | 67 | Search BAZEDOXIFENE | Search BAZEDOXIFENE |
2 | RALOXIFENE | 1109262 | 18% | 20% | 189 | Search RALOXIFENE | Search RALOXIFENE |
3 | TISSUE SELECTIVE ESTROGEN COMPLEX | 569440 | 2% | 83% | 24 | Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX | Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX |
4 | SELECTIVE ESTROGEN RECEPTOR MODULATOR | 483957 | 8% | 20% | 83 | Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR | Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR |
5 | LASOFOXIFENE | 409888 | 2% | 62% | 23 | Search LASOFOXIFENE | Search LASOFOXIFENE |
6 | TSEC | 379454 | 1% | 88% | 15 | Search TSEC | Search TSEC |
7 | SERM | 241248 | 5% | 17% | 50 | Search SERM | Search SERM |
8 | CONJUGATED ESTROGENS | 231686 | 3% | 29% | 28 | Search CONJUGATED+ESTROGENS | Search CONJUGATED+ESTROGENS |
9 | BREAST CANCER PREVENTION | 225324 | 2% | 30% | 26 | Search BREAST+CANCER+PREVENTION | Search BREAST+CANCER+PREVENTION |
10 | SERMS | 187091 | 4% | 17% | 39 | Search SERMS | Search SERMS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NELSON, HD , SMITH, B , GRIFFIN, JC , FU, RW , (2013) USE OF MEDICATIONS TO REDUCE RISK FOR PRIMARY BREAST CANCER: A SYSTEMATIC REVIEW FOR THE US PREVENTIVE SERVICES TASK FORCE.ANNALS OF INTERNAL MEDICINE. VOL. 158. ISSUE 8. P. 604 -+ | 71 | 75% | 45 |
2 | KOMM, BS , MIRKIN, S , (2014) AN OVERVIEW OF CURRENT AND EMERGING SERMS.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 143. ISSUE . P. 207 -222 | 62 | 52% | 43 |
3 | VISVANATHAN, K , HURLEY, P , BANTUG, E , BROWN, P , COL, NF , CUZICK, J , DAVIDSON, NE , DECENSI, A , FABIAN, C , FORD, L , ET AL (2013) USE OF PHARMACOLOGIC INTERVENTIONS FOR BREAST CANCER RISK REDUCTION: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 31. ISSUE 23. P. 2942-+ | 41 | 73% | 84 |
4 | KOMM, BS , MIRKIN, S , JENKINS, SN , (2014) DEVELOPMENT OF CONJUGATED ESTROGENS/BAZEDOXIFENE, THE FIRST TISSUE SELECTIVE ESTROGEN COMPLEX (TSEC) FOR MANAGEMENT OF MENOPAUSAL HOT FLASHES AND POSTMENOPAUSAL BONE LOSS.STEROIDS. VOL. 90. ISSUE . P. 71 -81 | 49 | 68% | 6 |
5 | LI, FX , DOU, JL , WEI, LJ , LI, SX , LIU, JT , (2016) THE SELECTIVE ESTROGEN RECEPTOR MODULATORS IN BREAST CANCER PREVENTION.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 77. ISSUE 5. P. 895 -903 | 38 | 81% | 1 |
6 | MOYER, VA , (2013) MEDICATIONS FOR RISK REDUCTION OF PRIMARY BREAST CANCER IN WOMEN: U. S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT.ANNALS OF INTERNAL MEDICINE. VOL. 159. ISSUE 10. P. 698 -+ | 35 | 81% | 31 |
7 | BAMBHROLIYA, A , CHAVEZ-MACGREGOR, M , BREWSTER, AM , (2015) BARRIERS TO THE USE OF BREAST CANCER RISK REDUCTION THERAPIES.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 13. ISSUE 7. P. 927 -935 | 36 | 77% | 3 |
8 | SHARIFI, M , LEWIECKI, EM , (2014) CONJUGATED ESTROGENS COMBINED WITH BAZEDOXIFENE: THE FIRST APPROVED TISSUE SELECTIVE ESTROGEN COMPLEX THERAPY.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 7. ISSUE 3. P. 281 -291 | 39 | 71% | 6 |
9 | ROETZHEIM, RG , LEE, JH , FULP, W , GOMEZ, EM , CLAYTON, E , TOLLIN, S , KHAKPOUR, N , LARONGA, C , LEE, MC , KILUK, JV , (2015) ACCEPTANCE AND ADHERENCE TO CHEMOPREVENTION AMONG WOMEN AT INCREASED RISK OF BREAST CANCER.BREAST. VOL. 24. ISSUE 1. P. 51 -56 | 28 | 88% | 9 |
10 | SMITH, CL , SANTEN, RJ , KOMM, B , MIRKIN, S , (2014) BREAST-RELATED EFFECTS OF SELECTIVE ESTROGEN RECEPTOR MODULATORS AND TISSUE-SELECTIVE ESTROGEN COMPLEXES.BREAST CANCER RESEARCH. VOL. 16. ISSUE 3. P. - | 49 | 56% | 1 |
Classes with closest relation at Level 1 |